IGES GmbH

About IGES GmbH

IGES GmbH is a research and consulting company in the healthcare sector focused on market access, evaluation, and successful introduction of pharmaceuticals and medical devices in Europe. The company emerged from the IGES Institut, founded in 1980, and bundles key business areas within the IGES Group under a common organizational structure. These include particularly the Pharma and Medtech divisions. In the Pharma division, IGES GmbH provides comprehensive services to support market access for pharmaceuticals. These include, among other things, the planning and execution of evidence generation, the creation and evaluation of Health Technology Assessments (HTA), the development of pricing and reimbursement strategies, as well as support for product launches and the entire product lifecycle. In the Medtech division, IGES GmbH offers sound analyses, strategies, and consulting for medical devices – from clinical and health economic evaluation to issues of reimbursement and market positioning. IGES GmbH bases its activities on sound scientific methods, comprehensive data analyses, and many years of experience in addressing health economic and healthcare policy issues, as well as evidence generation. Since 2025, the IGES Group has been part of the athagoras Group, which unites further companies from the fields of Regulatory Affairs, Pharmacovigilance, Real World Data, and IT in a total of twelve countries for the development and marketing of healthcare innovations.